Prescription drug · ANDA
deferasirox NDC 70771-1473
Deferasirox 360 mg/1 · Tablet, Film coated · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1473-1 | 70771147301 | 100 TABLET, FILM COATED in 1 BOTTLE (70771-1473-1)Marketed from Nov 21, 2019 | |
| 70771-1473-3 | 70771147303 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1473-3)Marketed from Nov 21, 2019 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- deferasirox
- Generic name (nonproprietary)
- deferasirox
- Active ingredients
- Deferasirox — 360 mg/1
- Dosage form
- Tablet, Film coated
- Route
- Oral
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211383
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 1A2 Inhibitors (Mechanism)Cytochrome P450 2C8 Inhibitors (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Iron Chelating Activity (Mechanism)
- Identifiers
- Product ID 70771-1473_9e909702-4471-4cd1-8e97-56b38fba9aa6SPL ID 9e909702-4471-4cd1-8e97-56b38fba9aa6SPL set ID fcd2ffe2-c8ba-400b-b7f9-e0e4b3510b98RxCUI 1607784, 1607792, 1607796UNII V8G4MOF2V9
- Pharmacologic class
- Iron Chelator
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771147301followed by a unit qualifier and the quantityPackage 70771-1473-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 211383
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| deferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1277 |
| deferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1275 |
| deferasirox | Deferasirox 180 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1276 |
| deferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1471 |
| deferasirox | Deferasirox 180 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1472 |